Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Metastatic Colorectal Cancer
Related studies linked through entity extraction aliases.
A Trial of Capecitabine (Xeloda), Oxaliplatin and Irinotecan in Combination With Bevacizumab in 1st Line Treatment of Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- N/A
IXO+A in mCRC With Liver-only Metastases
- Status
- WITHDRAWN
- Phase
- PHASE2
Trial of FOLF(HA)Iri Versus FOLFIRI in mCRC
- Status
- UNKNOWN
- Phase
- PHASE3
Study Assessing Potential Predictive Tumor Markers in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Simvastatin + Cetuximab/Irinotecan in K-ras Mutant Colorectal Cancer (CRC)
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- NA
Study of TF2 Carcinoembryonic Antigen (CEA) Antibody in Patients With Metastatic Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of IMMU-130 in Patients With Relapsed/Refractory Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Dual Targeting of Vascular Endothelial Growth Factor-A Together With Angiopoietins in Chemotherapy-naïve Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Intermittent Versus Continuous Tarceva Study
- Status
- COMPLETED
- Phase
- PHASE2
Study of NK012 and 5-FU/LV in Solid Tumors Followed by Dose Expansion in Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Trial to Compare Oxaliplatin, Folinic Acid (FA) and 5-Fluorouracil (5FU) Combination Chemotherapy (FOLFOX-4) With or Without Cetuximab in the 1st Line Treatment of Metastatic Colorectal Cancer (mCRC) in Chinese Rat Sarcoma Viral Oncogene Homolog (RAS) Wild-type Patients
- Status
- COMPLETED
- Phase
- PHASE3
Erbitux Study of CPT11, Oxaliplatin, UFToral Targeted Therapy
- Status
- COMPLETED
- Phase
- PHASE2
RSHF in Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
FOLFOXIRI Compared With FOLFIRI for Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Study of Circulating Markers in Serum of Patients Treated for Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- NA
A Genotype-guided Study of Irinotecan Administered in Combination With 5-fluorouracil/Leucovorin (FOLFIRI) and Bevacizumab in Advanced Colorectal Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
FOLFOX/Bevacizumab +/- MK-0646 in Metastatic Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2